ASX Announcement INOVIQ ANNOUNCES LEADERSHIP CHANGE Melbourne, Australia, 23 October 2026: INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a biotechnology company developing next-generation exosome-based diagnostics and therapeutics, today announced a planned leadership transition, with the Board...
INOVIQ Announces Leadership Change
Filed with ASX ·
6ix is reading this filing.
Earlier from Inoviq
- EXO-OC Technical Review and Commercialisation Pathway
- EXO-OC Study Outcome Investor Webinar Presentation
- Quarterly Activities Report and Appendix 4C - June 2026
- EXO-OC algorithm and clinical study update
- Positive CAR-exosome data in ovarian cancer
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq